Ind-Swift Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Ind-Swift Lab.	Bharat Parenterals	Anuh Pharma
Operational Metrics
Pharmaceuticals
Total reactor capacity	700.0 kL	n/a	n/a
DMF Filingsby API	474.0 .	n/a	n/a
R&D as a % of Total Sales	2.9 %	0.31 %	0.0
Financials
5 yr Average ROE	14.53 %	7.88 %	15.87 %
5yr average Equity Multiplier	2.17	1.84	1.62
5yr Average Asset Turnover Ratio	0.66	0.73	1.35
5yr Avg Net Profit Margin	16.17 %	5.85 %	7.23 %
Price to Book	0.6	2.29	2.43
P/E	3.27	0.0	20.49
5yr Avg Cash Conversion Cycle	15.71 Days	107.3 Days	42.81 Days
Inventory Days	103.91 Days	52.36 Days	50.87 Days
Days Receivable	105.66 Days	167.45 Days	111.12 Days
Days Payable	107.02 Days	103.87 Days	117.6 Days
5yr Average Interest Coverage Ratio	21.19	14.58	48.66
5yr Avg ROCE	12.09 %	9.5 %	21.17 %
5yr Avg Operating Profit Margin	14.94 %	9.16 %	10.21 %
5 yr average Debt to Equity	0.91	0.36	0.02
5yr CAGR Net Profit	n/a	n/a	10.73 %
5yr Average Return on Assets	11.49 %	5.04 %	9.84 %
Shareholdings
Promoter Holding	39.5 %	67.19 %	71.82 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.5 %	-6.65 %	1.23 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Ind-Swift Lab.	Bharat Parenterals	Anuh Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Bulk drug and Chemicals 0	Product Wise Break-Up Bulk drug and Chemicals 0 Pharmaceutical 0 Others 100	Product Wise Break-Up Bulk drug and Chemicals 100.0 Pharmaceutical 0
Location Wise Break-Up	Location Wise Break-Up India 27.72 Rest of the World 0 Others 72.28	Location Wise Break-Up India 23.83 Rest of the World 76.17	Location Wise Break-Up India 45.02 Rest of the World 0 Others 54.98
Operating Profit Break-Up	Operating Profit Break-Up India 18.87 Others 81.13	-	-
Asset Break-Up	Asset Break-Up India 67.55 Others 32.45	-	-